Approval · Notice of Compliance 9331 · 2008
HY-50: Notice of Compliance 9331
Issued January 30, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9331
- Date
- January 30, 2008
- Company
- Bexco Pharma Inc.Toronto, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional route of administration: intravenous
- Therapeutic class
- Antiarthritic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HY-50 | 02238566 | Marketed |
Medicinal ingredients
- HYALURONATE SODIUM 17 MG per ML